Finch Therapeutics Group Inc (FNCH)
2.485
-0.60
(-19.45%)
USD |
NASDAQ |
Apr 17, 16:00
2.46
-0.02
(-1.01%)
After-Hours: 20:00
Finch Therapeutics Group Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2023 | 0.00 |
December 31, 2022 | 0.1531 |
September 30, 2022 | 0.1211 |
June 30, 2022 | 0.0919 |
March 31, 2022 | 0.00 |
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.0076 |
December 31, 2020 | -0.0189 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0189
Minimum
Dec 2020
0.1531
Maximum
Dec 2022
0.0355
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
ACADIA Pharmaceuticals Inc | 0.00 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 55.37M |
Total Liabilities (Quarterly) | 32.49M |
Shareholders Equity (Quarterly) | 22.89M |